Cardlytics, Inc. (CDLX): Price and Financial Metrics


Cardlytics, Inc. (CDLX): $9.37

-0.44 (-4.49%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CDLX POWR Grades

  • Growth is the dimension where CDLX ranks best; there it ranks ahead of 40% of US stocks.
  • The strongest trend for CDLX is in Sentiment, which has been heading down over the past 177 days.
  • CDLX ranks lowest in Sentiment; there it ranks in the 0th percentile.

CDLX Stock Summary

  • In terms of twelve month growth in earnings before interest and taxes, CARDLYTICS INC is reporting a growth rate of 77.48%; that's higher than 81.85% of US stocks.
  • In terms of volatility of its share price, CDLX is more volatile than 95.79% of stocks we're observing.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CDLX comes in at 12.79% -- higher than that of 85.13% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to CARDLYTICS INC, a group of peers worth examining would be UAVS, EGLX, MOGO, UPLD, and COMP.
  • Visit CDLX's SEC page to see the company's official filings. To visit the company's web site, go to www.cardlytics.com.

CDLX Valuation Summary

  • CDLX's price/sales ratio is 1.3; this is 50% lower than that of the median Technology stock.
  • Over the past 56 months, CDLX's price/sales ratio has gone down 1.

Below are key valuation metrics over time for CDLX.

Stock Date P/S P/B P/E EV/EBIT
CDLX 2022-09-16 1.3 0.7 -2.6 -3.1
CDLX 2022-09-15 1.4 0.7 -2.7 -3.2
CDLX 2022-09-14 1.4 0.7 -2.7 -3.2
CDLX 2022-09-13 1.4 0.7 -2.8 -3.3
CDLX 2022-09-12 1.6 0.8 -3.1 -3.7
CDLX 2022-09-09 1.4 0.7 -2.8 -3.3

CDLX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CDLX has a Quality Grade of D, ranking ahead of 7.45% of graded US stocks.
  • CDLX's asset turnover comes in at 0.25 -- ranking 464th of 563 Business Services stocks.
  • 500 - Internal server error

The table below shows CDLX's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.250 0.377 -0.821
2021-06-30 0.294 0.364 -0.473
2021-03-31 0.386 0.343 -0.335
2020-12-31 0.622 0.339 -0.377
2020-09-30 0.754 0.347 -0.501
2020-06-30 0.989 0.360 -0.878

CDLX Price Target

For more insight on analysts targets of CDLX, see our CDLX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $105.00 Average Broker Recommendation 1.83 (Hold)

CDLX Stock Price Chart Interactive Chart >

Price chart for CDLX

CDLX Price/Volume Stats

Current price $9.37 52-week high $97.21
Prev. close $9.81 52-week low $8.68
Day low $8.68 Volume 500,700
Day high $9.63 Avg. volume 526,492
50-day MA $13.49 Dividend yield N/A
200-day MA $37.88 Market Cap 308.22M

Cardlytics, Inc. (CDLX) Company Bio


Cardlytics, Inc. operates purchase data intelligence platforms in the United States and the United Kingdom. The company operates through two segments, Cardlytics Direct and Other Platform Solutions. It operates Cardlytics Direct, a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels; and offers solutions that enable marketers and marketing service providers to leverage the power of purchase intelligence outside the banking channel. The company was founded in 2008 and is based in Atlanta, Georgia.


CDLX Latest News Stream


Event/Time News Detail
Loading, please wait...

CDLX Latest Social Stream


Loading social stream, please wait...

View Full CDLX Social Stream

Latest CDLX News From Around the Web

Below are the latest news stories about CARDLYTICS INC that investors may wish to consider to help them evaluate CDLX as an investment opportunity.

10 Best Stocks to Buy According to Ari Zweiman’s 683 Capital Partners

In this article, we present the list of top 10 stock picks of Ari Zweiman’s 683 Capital Partners at the end of the second quarter. If you want to skip the fund’s history, recent performance and details about its overall portfolio, please go directly to 5 Best Stocks to Buy According to Ari Zweiman’s 683 […]

Yahoo | September 19, 2022

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Cardlytics, Inc., (NASDAQ: CDLX), an advertising platform in banks’ digital channels, today announced that, on September 1, 2022, Cardlytics’ Board of Directors granted 1,345,261 restricted stock units of Cardlytics to Karim Temsamani, Cardlytics’ newly hired Chief Executive Officer. The foregoing restricted stock units were granted as a material inducement to employment with Cardlytics in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted

Yahoo | September 1, 2022

Cardlytics (CDLX) Gets a Hold Rating from Wells Fargo

In a report released today, Jeff Cantwell from Wells Fargo maintained a Hold rating on Cardlytics (CDLX – Research Report), with a price target of $14.00. The company's shares closed last Wednesday at $16.47, close to its 52-week low of $11.96. According to TipRanks.com, Cantwell is a 5-star analyst with an average return of 11.5% and a 64.4% success rate. Cantwell covers the Technology sector, focusing on stocks such as TELUS International (CDA), Fidelity National Info, and Bill.com Holdings. Currently, the analyst consensus on Cardlytics is a Hold with an average price target of $20.75, which is a 48.3% upside from current levels.

Christine Brown on TipRanks | August 3, 2022

Cardlytics, Inc. (CDLX) Q2 2022 Earnings Call Transcript

Thank you for standing by, and welcome to the second quarter 2022 Cardlytics, Inc. earnings conference call. For a discussion of the specific risk factors that could cause our actual results to differ materially from today's discussion, please refer to the risk factors section of the company's 10-Q for the quarter ended June 30, 2022, which has been filed with the Securities and Exchange Commission.

Yahoo | August 3, 2022

Cardlytics (CDLX) Reports Q2 Loss, Lags Revenue Estimates

Cardlytics (CDLX) delivered earnings and revenue surprises of -20.37% and 1.59%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | August 2, 2022

Read More 'CDLX' Stories Here

CDLX Price Returns

1-mo -31.05%
3-mo -58.47%
6-mo -83.12%
1-year -89.12%
3-year -72.05%
5-year N/A
YTD -85.82%
2021 -53.71%
2020 127.12%
2019 480.42%
2018 N/A
2017 N/A

Continue Researching CDLX

Want to see what other sources are saying about Cardlytics Inc's financials and stock price? Try the links below:

Cardlytics Inc (CDLX) Stock Price | Nasdaq
Cardlytics Inc (CDLX) Stock Quote, History and News - Yahoo Finance
Cardlytics Inc (CDLX) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.623 seconds.